No Data
No Data
$CGON Stock Is up 7% Today. Here's What We See in Our Data.
ANI Pharma Wins Overweight Rating at J.P. Morgan on Growth Prospects
CG Oncology to Participate in the 40th Annual European Association of Urology Congress With a Series of Key Presentations and Updates
3 Analysts Assess CG Oncology: What You Need To Know
CG Oncology Coverage Assumed by Morgan Stanley at Overweight
Morgan Stanley Initiates CG Oncology(CGON.US) With Buy Rating, Announces Target Price $55